Release Date: 25/01/11 09:53 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 34.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%